JD Bioscience
PrivateLast Round
Series B
Jul 1, 2021
Total Funding Raised
$21.97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
JD Bioscience operates in Healthcare & Life Sciences and is based in Gwangju. Its latest recorded funding round was a Series B round in July 2021.
JD Bioscience is a biotechnology company that engages in the research and development of small molecule-based novel therapeutics for metabolic diseases and functional cosmetics ingredients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JD Bioscience Comparables
Compare JD Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dong-A ST | 75% | |
| Novo Nordisk | 70% | |
| Hanmi Pharm Co Ltd | 69% |
For institutional investors. Book with your work email.
JD Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 1, 2021 | ||||
| Series A | Feb 1, 2019 | ||||
| Grant | Oct 1, 2017 | ||||
| Seed | Aug 1, 2017 |
For institutional investors. Book with your work email.
JD Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B |
| K2 Investment Partners | Series B |
| DAYLI Partners | Series B |
| Hyundai Venture Investment Corporation | Series A, Series B |
| UTC Investment | Series B |
| Synergy IB Investment | Series A, Series B |
| Sunbo Angel Partners | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 14, 200% of headcount.
- Apr 18, 2026
Monthly visitors increased 267% MoM, reaching 4.7K.
For institutional investors. Book with your work email.
JD Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about JD Bioscience's valuation, stock price, and market status.
Is JD Bioscience a public or private company?
JD Bioscience is a private company.
What is the current stock price of JD Bioscience?
JD Bioscience is a private company, so its shares have no public market price. Caplight tracks JD Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is JD Bioscience worth (valuation)?
Valuation information for JD Bioscience is not publicly available.
Can I buy JD Bioscience stock?
JD Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was JD Bioscience's last funding round?
JD Bioscience's most recent funding round was Series B on July 1, 2021.
Who are the main investors in JD Bioscience?
Key investors in JD Bioscience include Mirae Asset Capital.
Will JD Bioscience IPO soon?
No public IPO plans have been announced for JD Bioscience.
How can I track JD Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in JD Bioscience's shares on secondary markets.